
Welcome
Admissions
Curriculum
Seminar Program
Research
Faculty
Staff & PostDocs
Students
Alumni & Friends
Medicinal Chemistry HOME
|

|
John G. Topliss, Ph.D.
Professor of Medicinal Chemistry
University of Michigan, College of Pharmacy
The University of Michigan
College of Pharmacy
428 Church St.
Ann Arbor, Michigan 48109-1065
Phone: (734) 763-4998
jgt@umich.edu
Ph.D. Organic Chemistry, The University of Nottingham, UK.
Prior to joining the medicinal chemistry faculty, Dr. Topliss was engaged for many years in medicinal chemistry research in the pharmaceutical industry, and brings to the program a perspective of how drugs actually are discovered and developed in industry.
He began his career as a synthetic medicinal chemist with Schering-Plough Corp. in 1957 and rose to the position of senior director of chemical research in 1975. Four years later, he joined Warner-Lambert/Parke-Davis as director of chemistry, and from 1983 to 1991 was vice-president, chemistry, during which period he also held an adjunct faculty appointment in medicinal chemistry at the University of Michigan.
Dr. Topliss was among the first researchers in industry to become involved in the field of quantitative structure-activity relationships (QSAR). In the 1970s he developed non-statistical, non-computer-based methodology based on the Hansch principles, which has become widely recognized and is described in textbooks on medicinal chemistry as the Topliss Decision-Tree approach. The method delineates stepwise operational schemes for analog synthesis in drug design, addressing both aromatic substitution and side chain problems. A companion method, published some years later, extended the method to a batchwise compound selection procedure. In other work in the QSAR field, he was the first to study the phenomenon of chance correlations in QSAR studies using multiple regression techniques and his publications on this subject have been widely cited. A continued interest of his has been the practical application of QSAR methodology to problems of drug design, and he edited a book, published in 1983, that provided a systematic and critical review of this subject matter.
In addition to his work in the QSAR field, Dr. Topliss has been broadly involved as an individual researcher and as a research director in medicinal chemistry research directed to new drug discovery in a number of different therapeutic categories. Current research interests center on the broad subject of drug design and include new applications of QSAR methodology, and molecular diversity in relation to finding novel structural leads.
Dr. Topliss has maintained an active participation in various professional activities related to the medicinal chemistry field. He is currently past-president of the medicinal chemistry section of the International Union of Pure and Applied Chemistry.
Awards
- Elected Fellow AAAS, 1986
- ACS Division of Medicinal Chemistry Award, 1998
Selected Publications
- Some Observations on Classical QSAR. J.G. Topliss, Perspectives in Drug Discovery and Design, 1993, 1, 253-268.
- Computer-Aided Drug Design in Industrial Research A Management Perspective. J.G. Topliss, Chapter 2, Computer-Aided Drug Design in Industrial Research. Ernst Schering Research Foundation Workshop 15. Editors E.C. Herrmann and R. Franke, Springer-Verlag, Berlin, Heidelberg, 1995.
- Educating Medicinal Chemists. C.R. Ganellin, L.A. Mitscher and J.G. Topliss, Annual Reports in Medicinal Chemistry, Volume 30, Chapter 33, Academic Press, San Diego, 1995.
- Unified Model for the Corneal Permeability of Related and Diverse Compounds with Respect to Their Physicochemical Properties. F. Yoshida and J.G. Topliss, J. Pharm. Sci., 1996, 85, 819-823.
- Education of Medicinal Chemists in Departments of Medicinal Chemistry (USA). C.R. Ganellin, L.A. Mitscher and J.G. Topliss, Med. Res. Rev., 1998, 18, No. 2, 121-137.
- The Measurement of Molecular Diversity by Receptor Site Interaction Simulation, C.A. Parks, G.M. Crippen and J.G. Topliss, J. Comput.-Aided Mol. Design, 1998, 12, 441-449.
- University Education of Medicinal Chemists: Comparison of Eight Countries, C.R. Ganellin, L.A. Mitscher, B. Clement, T.-H. Kobayashi, E. Kyburtz, O. Lafont, A. Marcincal, A. Monge, G. Tarzia and J.G. Topliss, Eur. J. Med. Chem., 2000, 35, 163-174.
- QSAR Model for Drug Human Oral Bioavailability, F. Yoshida and J.G. Topliss , J. Med. Chem., 2000, 43, 2575-2585.
Questions/Comments
Rackham School of Graduate Studies | College of Pharmacy
page last modified: Wednesday, 27-Sep-2000 13:47:54 EDT
©2001 University of Michigan
|